Cargando…
Combined Prussian Blue Nanozyme Carriers Improve Photodynamic Therapy and Effective Interruption of Tumor Metastasis
INTRODUCTION: Photodynamic therapy (PDT) as a new technique for theranostics is to kill tumor cells by activating photosensitizer and interacting with oxygen (O(2)) to produce reactive oxygen species (ROS). However, the hypoxic tumor microenvironment (TME) may constrain the efficacy of PDT. Moreover...
Autores principales: | Shen, Wenhao, Han, Gaohua, Yu, Lei, Yang, Song, Li, Xiangyi, Zhang, Wei, Pei, Pei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964450/ https://www.ncbi.nlm.nih.gov/pubmed/35369032 http://dx.doi.org/10.2147/IJN.S359156 |
Ejemplares similares
-
Prussian Blue: A Nanozyme with Versatile Catalytic Properties
por: Estelrich, Joan, et al.
Publicado: (2021) -
Prussian Blue Nanozymes with Enhanced Catalytic Activity: Size Tuning and Application in ELISA-like Immunoassay
por: Khramtsov, Pavel, et al.
Publicado: (2022) -
Indocyanine Green-Conjugated Magnetic Prussian Blue Nanoparticles for Synchronous Photothermal/Photodynamic Tumor Therapy
por: Xue, Peng, et al.
Publicado: (2018) -
Oxygen‐Evolving Mesoporous Organosilica Coated Prussian Blue Nanoplatform for Highly Efficient Photodynamic Therapy of Tumors
por: Yang, Zhen Lu, et al.
Publicado: (2018) -
Prussian Blue Nanoparticle Supported MoS(2) Nanocomposites as a Peroxidase-Like Nanozyme for Colorimetric Sensing of Dopamine
por: Zhu, Zhiqiang, et al.
Publicado: (2022)